ANNOUNCEMENT

MedCity CONVERGE July 9-10 in Philly gathers payers, providers, medtech, pharma, digital health, policymakers & more.

Topic: publics

Medical device VP: What healthcare customers ask us for before buying a new technology

Medical device VP: What healthcare customers ask us for before buying a new technology

April 24, 2013 9:31 am by | 1 Comments

Healthcare craves innovation, but with innovation comes a certain amount risk. So when it comes to purchasing a new, innovative technology, healthcare providers, researchers and companies will naturally want to ... Read more
Device maker for minimally invasive GI procedures raises $3M, turns to GERD, obesity

Device maker for minimally invasive GI procedures raises $3M, turns to GERD, obesity

April 2, 2013 10:16 am by | 0 Comments

Investors have backed a company making disposable devices for minimally invasive gastroenterology procedures with a new $3 million in capital, according to a U.S. Securities and Exchange Commission filing.SafeStitch Medical’s ... Read more
BioDrain pulls in small round of capital as it pushes into medical waste management market

BioDrain pulls in small round of capital as it pushes into medical waste management market

March 26, 2013 1:32 pm by | 0 Comments

Publicly traded BioDrain Medical (OTC:BIOR) has been collecting some small private investments as it works to build buzz for its automated surgical fluid disposal device in U.S. hospitals and surgery ... Read more
Stem cell company Athersys expects more R&D spending, potential partnerships in 2013

Stem cell company Athersys expects more R&D spending, potential partnerships in 2013

March 13, 2013 10:16 am by | 1 Comments

Cleveland-based Athersys (NYSE:ATHX) has a full plate as it continues to advance its “off the shelf” stem cell therapy, MultiStem, through clinical trials in several indications. That means shareholders can ... Read more
Ampio carves out diagnostics program to advance oxidative stress measurement device

Ampio carves out diagnostics program to advance oxidative stress measurement device

March 8, 2013 10:02 am by | 0 Comments

Luoxis Diagnosis, a newly formed subsidiary of biopharmaceutical company Ampio Pharmaceuticals Inc. (NASDAQ: AMPE), is raising some private capital to move its diagnostics products forward.Ampio, which develops drugs to treat ... Read more
Mayo Clinic, UnitedHealth give collaborative twist to payer-provider integration with Optum Labs

Mayo Clinic, UnitedHealth give collaborative twist to payer-provider integration with Optum Labs

January 15, 2013 8:29 am by | 0 Comments

 SCROLL DOWN FOR UPDATEMayo Clinic and Optum, insurance giant UnitedHealth Group’s claims, health IT and health services division, announced that they are creating Optum Labs, a collaborative research and development ... Read more
Stryker CEO says firm’s foot and ankle business is taking on likes of Wright Medical & Arthrex

Stryker CEO says firm’s foot and ankle business is taking on likes of Wright Medical & Arthrex

January 9, 2013 2:37 pm by | 0 Comments

The 75 direct sales force dedicated to boost Stryker’s (NYSE: SYK)foot and ankle business unit had a stellar year in 2012, said CEO Kevin Lobo, to a packed room at ... Read more
Invacare divests medical supplies unit, reaches agreement with FDA on manufacturing issues

Invacare divests medical supplies unit, reaches agreement with FDA on manufacturing issues

December 24, 2012 12:06 pm by | 0 Comments

It’s a fitting conclusion to a tumultuous year for home health supply company Invacare Corp. (NYSE: IVC). In an effort to “reduce complexity” in its business and focus on its ... Read more
BioMarin, Prestige Brands and other top performing healthcare stocks in November

BioMarin, Prestige Brands and other top performing healthcare stocks in November

December 2, 2012 8:29 pm by | 0 Comments

Here is a quick look at some of the top-performing health care sector stocks in the past month. These companies all have a market cap of more than $500 million, ... Read more
St. Jude Medical’s $1B share buyback is move to shore stock battered over Durata worries

St. Jude Medical’s $1B share buyback is move to shore stock battered over Durata worries

November 30, 2012 12:04 pm by | 0 Comments

St. Jude Medical (NYSE:STJ) announced Thursday that its board has authorized a $1 billion share repurchase program.The move shows that the board believes that the company’s stock is undervalued, but ... Read more
Repurposed diagnostic agent nears phase 3 trials as a treatment for melanoma

Repurposed diagnostic agent nears phase 3 trials as a treatment for melanoma

November 26, 2012 3:12 pm by | 0 Comments

A compound used for years as a diagnostic agent for liver and eye cancer is nearing phase 3 clinical trials for a different purpose: to treat cancers and dermatological conditions.Provectus ... Read more
AspenBio Pharma takes another try at pivotal trial for blood test to rule out appendicitis

AspenBio Pharma takes another try at pivotal trial for blood test to rule out appendicitis

November 20, 2012 3:00 pm by | 0 Comments

 A few years ago, AspenBio Pharma (NASDAQ:APPY) was an animal health company struggling to navigate its way through commercialization of a human diagnostic test. Now, post-pivot with an updated management ... Read more
BSX’s $300M acquisition of Vessix Vascular shows continued consolidation in renal denervation

BSX’s $300M acquisition of Vessix Vascular shows continued consolidation in renal denervation

November 8, 2012 10:53 am by | 0 Comments

 UPDATED WITH ANALYST COMMENTBoston Scientific (NYSE:BSX) is jumping on the renal denervation bandwagon.The Natick, Massachusetts, medical device manufacturer announced Thursday that it is buying Caifornia startup Vessix Vascular for an ... Read more
Aspirin alternative to ward off cardiovascular disease could improve patient adherence

Aspirin alternative to ward off cardiovascular disease could improve patient adherence

November 6, 2012 7:06 pm by | 0 Comments

Low-dose aspirin or baby aspirin has been widely prescribed as a prevention measure against heart attacks and strokes. But about 15 percent of patients prescribed this treatment cannot take it ... Read more
Oncology company gets $10M to market oral rinse for chemotherapy side effect mucositis

Oncology company gets $10M to market oral rinse for chemotherapy side effect mucositis

November 6, 2012 1:42 pm by | 0 Comments

A Texas oncology company has completed a $10M private placement so it can continue commercialization of its mouthwash for chemotherapy side effect mucositis. ... Read more